Cargando…

Predictive value of circulating osteonectin in patients with ischemic symptomatic chronic heart failure

BACKGROUND: Osteonectin (OSN) plays a pivotal role in cardiac remodeling, but predictive value for OSN in ischemic chronic heart failure (CHF) has not been defined. The aim of the study was to evaluate the prognostic value of OSN for cumulative survival and hospitalization among patients with ischem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berezin, Alexander E., Kremzer, Alexander A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chang Gung University 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138259/ https://www.ncbi.nlm.nih.gov/pubmed/27013452 http://dx.doi.org/10.1016/j.bj.2015.08.002

Ejemplares similares

Circulating Endothelial-Derived Apoptotic Microparticles in the Patients with Ischemic Symptomatic Chronic Heart Failure: Relevance of Pro-Inflammatory Activation and Outcomes
por: Berezin, Alexander E., et al.
Publicado: (2014)

The predictive role of circulating microparticles in patients with chronic heart failure()
por: Berezin, Alexander E., et al.
Publicado: (2014)

Circulating thrombospondin-2 in patients with moderate-to-severe chronic heart failure due to coronary artery disease
por: Berezin, Alexander E., et al.
Publicado: (2016)

The signature of circulating microparticles in heart failure patients with metabolic syndrome
por: Berezin, Alexander E, et al.
Publicado: (2016)

Serum Uric Acid Predicts Declining of Circulating Proangiogenic Mononuclear Progenitor Cells in Chronic Heart Failure Patients
por: Berezin, Alexander E., et al.
Publicado: (2014)

Pattern of circulating microparticles in chronic heart failure patients with metabolic syndrome: Relevance to neurohumoral and inflammatory activation
por: Berezin, Alexander E., et al.
Publicado: (2015)

The Association of Subclinical Hypothyroidism and Pattern of Circulating Endothelial-Derived Microparticles Among Chronic Heart Failure Patients
por: Berezin, Alexander E., et al.
Publicado: (2015)

The utility of biomarker risk prediction score in patients with chronic heart failure
por: Berezin, Alexander E., et al.
Publicado: (2016)

Predictive value of serum irisin for chronic heart failure in patients with type 2 diabetes mellitus
por: Berezin, Alexander A., et al.
Publicado: (2022)

Analysis of Various Subsets of Circulating Mononuclear Cells in Asymptomatic Coronary Artery Disease
por: Berezin, Alexander E., et al.
Publicado: (2013)

Pattern of endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejection fraction
por: Berezin, Alexander E., et al.
Publicado: (2016)

Prognostication in Different Heart Failure Phenotypes: The Role of Circulating Biomarkers
por: Berezin, Alexander E.
Publicado: (2016)

Adropin Predicts Chronic Kidney Disease in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure
por: Berezina, Tetiana A., et al.
Publicado: (2023)

Low Plasma Levels of Irisin Predict Acutely Decompensated Heart Failure in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure
por: Berezin, Alexander A., et al.
Publicado: (2023)

Discriminative Value of Serum Irisin in Prediction of Heart Failure with Different Phenotypes among Patients with Type 2 Diabetes Mellitus
por: Berezin, Alexander A., et al.
Publicado: (2022)

Expression of osteopontin and osteonectin in breast cancer.
por: Kim, Y. W., et al.
Publicado: (1998)

Osteonectin bidirectionally regulates osteoblast mineralization
por: Zhu, Yun‑Sen, et al.
Publicado: (2023)

Editorial: Prognostication of Heart Failure Evolution: From Circulating Biomarkers to Genetic Risk Predictive Score
por: Berezin, Alexander E., et al.
Publicado: (2021)

Data regarding association between serum osteoprotegerin level, numerous of circulating endothelial-derived and mononuclear-derived progenitor cells in patients with metabolic syndrome
por: Berezin, Alexander E., et al.
Publicado: (2016)

Biomarkers in Heart Failure: From Research to Clinical Practice
por: Berezin, Alexander E., et al.
Publicado: (2023)

Circulating Osteonectin and Adipokine Profiles in Relation to Metabolically Healthy Obesity in Chinese Children: Findings From BCAMS
por: Fu, Junling, et al.
Publicado: (2018)

Epigenetics in heart failure phenotypes()
por: Berezin, Alexander
Publicado: (2016)

Serum Levels of Irisin Predict Cumulative Clinical Outcomes in Heart Failure Patients With Type 2 Diabetes Mellitus
por: Berezin, Alexander A., et al.
Publicado: (2022)

Thrombospondin-2 and SPARC/osteonectin are critical regulators of bone remodeling
por: Delany, Anne M., et al.
Publicado: (2009)

Extracellular Endothelial Cell-Derived Vesicles: Emerging Role in Cardiac and Vascular Remodeling in Heart Failure
por: Berezin, Alexander E., et al.
Publicado: (2020)

Emerging Role of Adipocyte Dysfunction in Inducing Heart Failure Among Obese Patients With Prediabetes and Known Diabetes Mellitus
por: Berezin, Alexander E., et al.
Publicado: (2020)

Serum Uric Acid as a Marker of Coronary Calcification in Patients with Asymptomatic Coronary Artery Disease with Preserved Left Ventricular Pump Function
por: Berezin, A. E., et al.
Publicado: (2013)

The Effect of SGLT2 Inhibitor Dapagliflozin on Serum Levels of Apelin in T2DM Patients with Heart Failure
por: Berezin, Alexander A., et al.
Publicado: (2022)

Osteonectin as a screening marker for pancreatic cancer: A prospective study
por: Papapanagiotou, Angeliki, et al.
Publicado: (2018)

Immunohistochemical expression of osteonectin, matrix metalloproteinases-9 and Ki-67 in ameloblastoma
por: Indirapriyadarsini, K, et al.
Publicado: (2018)

Myokines and Heart Failure: Challenging Role in Adverse Cardiac Remodeling, Myopathy, and Clinical Outcomes
por: Berezin, Alexander E., et al.
Publicado: (2021)

Osteocalcin and osteonectin expression after double application of platelet-rich plasma in rabbits
por: Ozdemir, Burcu, et al.
Publicado: (2016)

Interplay between Myokine Profile and Glycemic Control in Type 2 Diabetes Mellitus Patients with Heart Failure
por: Berezin, Alexander A., et al.
Publicado: (2022)

Editorial: Acute heart failure: From bench to bedside
por: Berezin, Alexander E., et al.
Publicado: (2023)

Discriminative Utility of Apelin-to-NT-Pro-Brain Natriuretic Peptide Ratio for Heart Failure with Preserved Ejection Fraction among Type 2 Diabetes Mellitus Patients
por: Berezin, Alexander A., et al.
Publicado: (2022)

Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization
Publicado: (1988)

Editorial: Epigenetics in Heart Failure Developing: The Orchestra of Etiology and Comorbidities
por: Berezin, Alexander E., et al.
Publicado: (2022)

Circulating lncRNA MHRT predicts survival of patients with chronic heart failure
por: Zhang, Li-E, et al.
Publicado: (2019)

Expression Analysis of SPARC/Osteonectin in Oral Squamous Cell Carcinoma Patients: From Saliva to Surgical Specimen
por: Aquino, Gabriella, et al.
Publicado: (2013)

The Impact of SGLT2 Inhibitor Dapagliflozin on Adropin Serum Levels in Men and Women with Type 2 Diabetes Mellitus and Chronic Heart Failure
por: Berezin, Alexander A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j47fm8q0trlk49p8doiqtu6bt9